Lumos Pharma Inc
NASDAQ:LUMO
Lumos Pharma Inc
NASDAQ:LUMO
Price:
4.34
USD
Market Cap:
$37.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Lumos Pharma Inc
NASDAQ:LUMO
|
US |
|
Knowles Corp
NYSE:KN
|
US |
|
Mahindra EPC Irrigation Ltd
NSE:MAHEPC
|
IN |
Balance Sheet
Balance Sheet Decomposition
Lumos Pharma Inc
Lumos Pharma Inc
Balance Sheet Decomposition is not available for
Lumos Pharma Inc
Lumos Pharma Inc
Balance Sheet
Lumos Pharma Inc
Lumos Pharma Inc
Currency: USD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
190
|
196
|
132
|
159
|
121
|
91
|
99
|
95
|
56
|
35
|
|
| Cash Equivalents |
190
|
196
|
132
|
159
|
121
|
91
|
99
|
95
|
56
|
35
|
|
| Short-Term Investments |
12
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
11
|
1
|
|
| Total Receivables |
13
|
5
|
31
|
11
|
1
|
1
|
26
|
0
|
0
|
0
|
|
| Other Current Assets |
8
|
5
|
6
|
6
|
6
|
3
|
4
|
5
|
4
|
4
|
|
| Total Current Assets |
224
|
208
|
168
|
176
|
127
|
94
|
128
|
100
|
72
|
40
|
|
| PP&E Net |
8
|
10
|
7
|
5
|
4
|
2
|
1
|
1
|
0
|
1
|
|
| PP&E Gross |
8
|
10
|
7
|
5
|
4
|
2
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
5
|
7
|
6
|
7
|
7
|
8
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
231
N/A
|
219
-5%
|
175
-20%
|
181
+3%
|
131
-28%
|
97
-26%
|
129
+33%
|
100
-22%
|
72
-28%
|
41
-44%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
4
|
23
|
9
|
1
|
1
|
0
|
1
|
0
|
1
|
|
| Accrued Liabilities |
9
|
9
|
14
|
13
|
8
|
11
|
6
|
5
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
13
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
25
|
15
|
38
|
22
|
9
|
12
|
7
|
5
|
7
|
7
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
8
|
8
|
7
|
7
|
7
|
6
|
6
|
6
|
6
|
6
|
|
| Total Liabilities |
34
N/A
|
23
-34%
|
45
+99%
|
29
-36%
|
16
-46%
|
18
+13%
|
13
-30%
|
11
-10%
|
13
+12%
|
13
+5%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
40
|
80
|
166
|
238
|
291
|
334
|
66
|
96
|
128
|
162
|
|
| Additional Paid In Capital |
237
|
277
|
296
|
390
|
407
|
414
|
183
|
185
|
187
|
189
|
|
| Treasury Stock |
0
|
1
|
1
|
1
|
1
|
2
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
197
N/A
|
196
-1%
|
130
-34%
|
152
+17%
|
115
-24%
|
79
-31%
|
117
+48%
|
89
-24%
|
60
-33%
|
27
-54%
|
|
| Total Liabilities & Equity |
231
N/A
|
219
-5%
|
175
-20%
|
181
+3%
|
131
-28%
|
97
-26%
|
129
+33%
|
100
-22%
|
72
-28%
|
41
-44%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
4
|
4
|
4
|
8
|
8
|
8
|
8
|
|
Switch to:
Switch to:
See Also
Discover More
